Medica — AGM Information 2023

Apr 28, 2023

MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY

Tel. 0535 51159 Fax 0535 52605 e-mail: info@medica.it home page: www.medica.it

International: Tel. +39 0535 51159 Fax +39 0535 52605

Press release

MEDICA S.P.A.

APPROVED THE FINANCIAL STATEMENT AS OF 31 DECEMBER 2022 AND THE DESTINATION OF THE NET INCOME; PRESENTED THE CONSOLIDATED FINANCIAL STATEMENT AS OF 31 DECEMBER 2022; APPOINTED THE INDEPENDENT AUDITORS; DETERMINED THE REMUNERATION OF THE BOARD OF DIRECTORS

Medolla (MO), 28 April 2023 – Medica S.p.A., an integrated Italian biomedical and MedTech group with a strong international footprint, announces that the ordinary shareholders' meeting, held today under the chairmanship of Luciano Fecondini, approved the financial statement as of 31 December 2022, closed with a net profit of Euro 3,519,307, together with the proposal of the Board of Directors to allocate the profit for the year to the legal reserve for Euro 175,965, equal to 5% of the Profit, and to the statutory reserve for Euro 3,343,342.

The Shareholders' Meeting also took note of the results of the consolidated financial statements as at 31 December 2022, approved the motivated opinion of the Board of Statutory Auditors regarding the assignment of statutory auditing of the Company for the three-year period 2023-2025, appointing EY S.p.A. as independent auditors with an annual fee of Euro 45,000.00, and approved the gross remuneration of the entire Board of Directors for the 2023 financial year alone, equal to Euro 192,000.00.

The company announces that a copy of the 2022 financial statements of Medica Spa and the 2022 consolidated financial statements of the Medica Group can be consulted at the registered office, as well as on the website of Medica Spa www.medica.it, in the 'Investors / Balance Sheet' section and on the Borsa Italiana website. It should also be noted that this press release is published on the website of Medica Spa www.medica.it, in the 'Investors / Press Releases' section.

The minutes of today's shareholders' meeting will be made available within the terms of current legislation and will be available at the registered office, as well as on the website of Medica Spa www.medica.it, in the 'Investors / Shareholders' Meeting' section and on the Borsa Italiana website.

Medica Profile

Medica Group is operating since 1985 in the biomedical district of Mirandola (Italy). Development of innovative products for blood purification has always been company's core business. Thanks to the activity of

***

UNI CEI EN ISO 9001:2015 UNI CEI EN ISO 13485:2016

Capitale sociale € 4.223.250,00 i.v. – Registro Ditte/REA n° 229672 – Registro Imprese di Modena n° 01604300366 Iscrizione Registro Nazionale Produttori A.E.E. n. IT08020000003645 Partita IVA e Codice Fiscale 01604300366 – Identification Number IT 01604300366

MEDICA S.p.A. Via Degli Artigiani, 7 41036 MEDOLLA MODENA - ITALY

Tel. 0535 51159 Fax 0535 52605 e-mail: info@medica.it home page: www.medica.it

International: Tel. +39 0535 51159 Fax +39 0535 52605

two extremely dynamic R&D groups (medical equipment, membranes and disposable), the Group competes successfully in several markets, namely:

• Medical (dialysis, CRRT, ECCO2, Apheresis, DFPP, CHF, HIPEC, pre-transplant organ perfusion, bioregenerative medicine, gastroenterology, urodynamics, oxygen humidification).
• Microbiological purification of water
• Industrial automation for the biomedical sector.

R&D focus has been integrated over the years with a highly automated production systems in several facilities, and with different commercial entities, both in Italy and abroad.

The key success factors of the Group are:

• extrusion of hollow fiber membranes for hemofiltration, plasmapheresis, cascade filtration, oxygen humidification, ultrafiltration and microfiltration of water
• vertical integration, proved by the ability to manage not only the design and development of medical disposables and equipment, and the development of the automation technologies required for their production as well.
• International recognition with significant share of export, with sales in over 60 countries.

For information: Investor Relations Medica Giovanni Plasmati (+39) 0535 51159 giovanni.plasmati@medica.it

Euronext Growth Advisor CFO SIM S.p.A. (+39) 02 303431 ecm@cfosim.com